In vitro studies on the effect of yolk sac antisera on functions of the visceral yolk sac: I. Pinocytosis and transport of small molecules. 1986

S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent

The production of congenital malformations by the administration of teratogenic antisera to pregnant animals has been reported from many laboratories. This work has focused our attention on the importance of the yolk sac placenta in supporting the rat embryo during early organogenesis and the significance of yolk sac dysfunction in rodent teratogenesis. The studies reported in this article deal with the effect of teratogenic antisera on the process of yolk sac transport; specifically pinocytosis (as measured by 14C-sucrose uptake) and small-molecule transport utilizing 14C-alpha-aminoisobutyric acid (AIB) and 3H-2-deoxyglucose (DOG). We sought to determine whether several different yolk sac localizing antibodies interfere with these transport processes, and, if so, which transport processes were most affected. The results of the experiments indicated that teratogenic antisera interfered with the process of pinocytosis in the yolk sac and that pinocytosis can be reduced as much as 40%. Nonteratogenic antisera, even when they localized in the yolk sac, did not interfere with the process of pinocytosis. Furthermore, the teratogenic antisera did not interfere with the transport of small molecules (either AIB or DOG) in the yolk sac. These results indicated that while fluorescent localization of an antiserum in the yolk sac did not invariably indicate the potential for teratogenicity, it is likely that the reduction in pinocytosis may directly correlate with the teratologic and embryopathic events. This work reaffirms the view that the yolk sac in important during rodent organogenesis and that yolk sac dysfunction can play an important role in the development of congenital malformations.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010873 Pinocytosis The engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles. Pinocytoses
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D005260 Female Females
D000013 Congenital Abnormalities Malformations of organs or body parts during development in utero. Birth Defects,Congenital Defects,Deformities,Fetal Anomalies,Fetal Malformations,Abnormalities, Congenital,Defects, Congenital,Abnormality, Congenital,Anomaly, Fetal,Birth Defect,Congenital Abnormality,Congenital Defect,Defect, Birth,Defect, Congenital,Deformity,Fetal Anomaly,Fetal Malformation,Malformation, Fetal
D000621 Aminoisobutyric Acids A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid. Acids, Aminoisobutyric

Related Publications

S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
June 1991, Teratology,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
January 1975, The Journal of cell biology,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
October 1977, The Journal of biological chemistry,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
November 1984, Journal of reproduction and fertility,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
December 1972, Teratology,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
April 1990, Teratology,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
February 2016, Biochemical and biophysical research communications,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
June 1978, The Journal of physiology,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
December 1978, Biochimica et biophysica acta,
S Lerman, and T R Koszalka, and M Jensen, and C L Andrew, and D A Beckman, and R L Brent
February 1987, Development (Cambridge, England),
Copied contents to your clipboard!